"Tianjiang" Concentrated TCM Granule Exports Grow
Jiangsu Tianjiang Pharmaceutical Co., Ltd. is the pilot unit for TCM decoction-piece reform designated by the State Administration of Traditional Chinese Medicine. Founded in 1992, the company made its first US export in 1995, and foreign-trade business has since grown 20% per year. From January through December 2000, exports rose 87% year on year. Tianjiang has become a stable supplier to major international firms in the United States, Germany, and elsewhere.
In recent years, Chinese medicine and herbs have become ever more welcome; the ideas of "green medicine" and "natural health-keeping" have gradually taken hold. But the inconvenience of decocting and taking traditional Chinese medicine has long held back the development of TCM and slowed its scientization and internationalization. Against this background, Tianjiang was the first in China to explore decoction-piece reform in 1992. Over the past eight years, the company has carried out deep research across six dimensions — processing-quality standards, pharmacodynamics, equivalence, pharmacology, clinical application, and so on — establishing production processes and quality standards for nearly 500 concentrated TCM granules and building several large herb-cultivation bases. At present, the company's single-herb concentrated granules are used in 28 provinces (regions and municipalities) and over 300 large and mid-sized hospitals in China, serving nearly a hundred million patients, and are exported to 25 countries and regions including the United States, Canada, the United Kingdom, Germany, the Netherlands, Australia, Southeast Asia, and South Africa.
Excerpted from China Traditional Chinese Medicine News, January 17, 2001